Skip to content

Clinical trials

Cholangiocarcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Australia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20142
20152
20161
20173
20181
20195
20205
20214
20224
20234
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting9
Terminated8
Active, not recruiting6
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Taiho Oncology, Inc.2
AbbVie1
Actym Therapeutics, Inc.1
Amgen1
Arbele Pty Ltd1
AstraZeneca1
Austin Health1
Australasian Gastro-Intestinal Trials Group1
Bayer1
Beijing InnoCare Pharma Tech Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma38
Breast Neoplasms10
Carcinoma, Non-Small-Cell Lung10
Pancreatic Neoplasms10
Bile Duct Neoplasms9
Colorectal Neoplasms9
Biliary Tract Neoplasms8
Ovarian Neoplasms8
Head and Neck Neoplasms7
Neoplasm Metastasis7

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.